They can be Osprey's figures. At $350USD per unit, Osprey would need DyeVert to be used in just over 2.85 million procedures a year for $1 billion in annual revenue. There are 75 million CT scans in the world every year. 40 million MRI scans every year in the US. About 1 million cardiac cath lab procedures in the US every year. Those numbers grow every year. The amount of contrast media used worldwide roughly doubles every 10 years (mostly population growth but also improved access to medical facilities) therefore so do the scans. You can play with the numbers to come up with different scenarios but the revenue is there once DyeVert becomes the procedure of choice.
OSP Price at posting:
4.4¢ Sentiment: Buy Disclosure: Held
